Embolism risk following systemic intravascular administration of mesenchymal stem cells in preclinical and clinical studies
WANG Yan
LI Hua
TANG Na-ping
WEI Li-ping
MA Jing
Machine-generated Keywords:
Publication Date:2020-10-31
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:6( 2315-2320 )
Chinese Journal of New Drugs

Chinese Journal of New Drugs

PKUISTIC
ISSN:1003-3734
Year, Vol.(Issue):2020,29(20)